Evaluation of precise hepatectomy for primary liver cancer
10.3760/cma.j.issn.1673-9752.2010.01.010
- VernacularTitle:精准肝切除治疗原发性肝癌的疗效评价
- Author:
Yudong QIU
;
Xinhua ZHU
;
Qingxiang XU
;
Yafu WU
;
Jianxin ZHOU
;
Yitao DING
- Publication Type:Journal Article
- Keywords:
Liver neoplasms;
Precise hepatectomy;
Efficacy
- From:
Chinese Journal of Digestive Surgery
2010;9(1):21-23
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the therapeutic effect and safety of precise hepatectomy for primary liver cancer.nethods A total of 103 liver cancer patients who had been admitted to Drum Tower Hospital from July 2007 to October 2009 were divided into precise hepatectomy group(n=54)and routine hepatectomy group (n=49).Peri-and postoperative conditions and the results of follow-up of patients in the 2 groups were compared.All data were analyzed via t test or Fisher exact test.Results No perioperative mortality was observed in the 2 groups.Mean blood loss was(635±608)ml in precise hepatectomy group and(929±1044)ml in routine hepatectomy group,with no significant difference between the 2 groups(t=1.722,P>0.05).Intraoperative blood transfusion volume,postoperative level of aspartate transaminase,positive rate of resection margin and incidence of postoperative complications were(222±381)ml,(158±121)U/L,2%(1/54)and 7%(4/54)in precise hepatectomy group,and were(542±785)ml,(292±347)U/L,18%(9/49)and 24%(12/49)in routine hepatectomy group,with significant difference between the 2 groups(t=2.590,2.558,P<0.05).The 1-year tumor recurrence rate and 1-year survival were 24%(8/33)and 85%(28/33)in precise hepatectomy group,42%(20/48)and 77%(37/48)in routine hepatectomy group,with no significant difference(P>0.05).Conclusion Precise hepatectomy is safe and effective in the treatment of liver caner without much injury to patients.
